
Syndax Pharmaceuticals is a biotechnology business based in the US. Syndax Pharmaceuticals shares (SNDX) are listed on the NASDAQ and all prices are listed in US Dollars. Syndax Pharmaceuticals employs 107 staff and has a trailing 12-month revenue of around $126.6 million.
How to buy Syndax Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SNDX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Syndax Pharmaceuticals stock price (NASDAQ: SNDX)
Use our graph to track the performance of SNDX stocks over time.Syndax Pharmaceuticals shares at a glance
Latest market close | $23.07 |
---|---|
52-week range | $13.27 - $29.86 |
50-day moving average | $25.54 |
200-day moving average | $22.94 |
Wall St. target price | $33.38 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.36 |
Buy Syndax Pharmaceuticals stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Syndax Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Syndax Pharmaceuticals price performance over time
Historical closes compared with the close of $23.07 from 2023-03-21
1 week (2023-03-15) | 3.45% |
---|---|
1 month (2023-02-22) | -9.17% |
3 months (2022-12-22) | -8.52% |
6 months (2022-09-22) | 1.14% |
1 year (2022-03-18) | 38.06% |
---|---|
2 years (2021-03-22) | -5.02% |
3 years (2020-03-20) | 170.77% |
5 years (2018-03-22) | 59.21% |
Syndax Pharmaceuticals financials
Revenue TTM | $126.6 million |
---|---|
Gross profit TTM | $139.7 million |
Return on assets TTM | -20.03% |
Return on equity TTM | -34.1% |
Profit margin | 0% |
Book value | $6.86 |
Market capitalisation | $1.5 billion |
TTM: trailing 12 months
Syndax Pharmaceuticals share dividends
We're not expecting Syndax Pharmaceuticals to pay a dividend over the next 12 months.
Syndax Pharmaceuticals share price volatility
Over the last 12 months, Syndax Pharmaceuticals's shares have ranged in value from as little as $13.27 up to $29.86. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syndax Pharmaceuticals's is 1.0393. This would suggest that Syndax Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Syndax Pharmaceuticals overview
Syndax Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 for the treatment of KMT2A rearranged (KMT2Ar) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
Syndax Pharmaceuticals in the news
Syndax Pharmaceuticals (SNDX) Stock Sinks As Market Gains: What You Should Know
Syndax Pharmaceuticals (SNDX) Dips More Than Broader Markets: What You Should Know
Syndax Pharmaceuticals Announces Two Publications in Nature of Data from the Phase 1 Portion of AUGMENT-101 in Acute Leukemia Patients
Frequently asked questions
What percentage of Syndax Pharmaceuticals is owned by insiders or institutions?Currently 4.198% of Syndax Pharmaceuticals shares are held by insiders and 106.301% by institutions. How many people work for Syndax Pharmaceuticals?
Latest data suggests 107 work at Syndax Pharmaceuticals. When does the fiscal year end for Syndax Pharmaceuticals?
Syndax Pharmaceuticals's fiscal year ends in December. Where is Syndax Pharmaceuticals based?
Syndax Pharmaceuticals's address is: 35 Gatehouse Drive, Waltham, MA, United States, 02451 What is Syndax Pharmaceuticals's ISIN number?
Syndax Pharmaceuticals's international securities identification number is: US87164F1057 What is Syndax Pharmaceuticals's CUSIP number?
Syndax Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 87164F105
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert